e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
New strategies and drugs for smoking cessation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
How to predict COPD in a clinical setting
C. Jimenez Ruiz (Madrid, Spain)
Source:
Annual Congress 2005 - New strategies and drugs for smoking cessation
Session:
New strategies and drugs for smoking cessation
Session type:
Hot topics
Number:
1313
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Jimenez Ruiz (Madrid, Spain). How to predict COPD in a clinical setting. Annual Congress 2005 - New strategies and drugs for smoking cessation
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Assessing the multivariate structure and influence of comorbidity in COPD
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
Developing COPD – a 25 year follow-up study of the general population
Source: Annual Congress 2005 - Better understanding of lung function decline and COPD
Year: 2005
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
COPD screening and risk factor frequency identification study
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Early detection of undiagnosed COPD in general practice; the yield of population-based screening according to socioeconomic status
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013
Pilot: identification of rehospitalization risk factors for patients with COPD
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005
COPD coronary/peripheral vascular disease
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories
Source: Eur Respir J, 58 (5) 2004656; 10.1183/13993003.04656-2020
Year: 2021
Spirometry screening in the community: is this an effective way of diagnosing early COPD?
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005
Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
COPD specific comorbidities: A prospective, objective and controlled evaluation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Detecting undiagnosed COPD: Using routine primary care data to select and validate candidate variables for COPD risk prediction
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013
Epidemiology, risk factors, and clinical parameters of non-smoker COPD patients.
Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Year: 2020
The future of disease monitoring and management: the homework for clinical researchers
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005
Predictive validity of SF-36 general health (GH) scale for COPD exacerbation
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005
Different definitions in childhood asthma: how dependable is the dependent variable?
Source: Eur Respir J 2010; 36: 48-56
Year: 2010
Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project
Source: Eur Respir J 2012; 39: 1343-1353
Year: 2012
COPD exacerbation definitions, assessment and diagnosis
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013
COPDCoRi, an algorithm for predicting the risk of coronaropathy in COPD patients
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Proteinase-inhibitor system state in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept